Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
HER2 Positive Gastric Cancer - Pipeline Insight, 2022
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
MEA Cervical Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030 Market Segmentation Middle East and Africa ... Read More
-
Adenoid Cystic Carcinoma - Pipeline Insight, 2022
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Global IDO Inhibitors Market Research Report 2022-2032
... global IDO Inhibitors Market market size, share, growth, scenario, latest trends and drivers, and the overall market environment. The study was conducted using an objective combination of primary and secondary information including inputs from key ... Read More
-
Head and Neck cancer - Pipeline Insight, 2022
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2022
... Delta Virus (HDV) Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More
-
Peritoneal Cancer - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Global Melanoma Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. Market Segmentation Global Melanoma Cancer Diagnostics Market, By Product ... Read More
-
Human papillomavirus 16-positive (HPV16+) cancers - Pipeline Insight, 2022
... cancers pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
MEA Ovarian Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. Market Segmentation Middle East and Africa Ovarian Cancer Diagnostics Market- ... Read More
-
APAC Cervical Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030 Market Segmentation Asia-Pacific Cervical Cancer Diagnostic Market, By Product ... Read More
-
NA Cervical Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030 Market Segmentation North America Cervical Cancer Diagnostic Market, ... Read More
-
Europe Cervical Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030 Market Segmentation Europe Cervical Cancer Diagnostic Market, By Product ... Read More
-
Cancer Immunotherapy Market Insights, Competitive Landscape and, Market Forecast - 2027
... AND OTHERS), BY END-USER (HOSPITALS AND CLINICS, SPECIALTY CENTERS, AND OTHERS), AND BY GEOGRAPHY IS EXPECTED TO RISE AT A SIGNIFICANT CAGR FORECAST TILL 2027 OWING TO THE ACCELERATING PREVALENCE OF CANCERS AND SURGING HEALTHCARE ... Read More
-
Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2022
... Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
Lung Adenocarcinoma - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Global Cervical Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030 Market Segmentation Global Cervical Cancer Diagnostic Market, By Product ... Read More
-
PEGylated Proteins Market Size, Share & Trends Analysis Report By Protein Type (CSF, Interferons), By Application (Cancer, Hepatitis), By Product & Services (Consumables, Services), By End-user, And Segment Forecasts, 2022 - 2030
... Growth & Trends The global PEGylated proteins market size is expected to reach USD 3.06 billion by 2030, registering a CAGR of 11.71% over the forecast period, according to a new report by Grand View ... Read More
-
Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Gallbladder Cancer (Oncology) pipeline landscape. Gallbladder cancer is a cancer that starts in the gallbladder. Symptoms include abdominal pain, nausea and/or vomiting, jaundice, loss of appetite, fever, itchy skin, dark ... Read More
-
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape. Non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in cells called lymphocytes, which are part of ... Read More
-
Gliosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Gliosarcoma (Oncology) pipeline landscape. Gliosarcoma is a type of brain tumor that originates from glial cells. The tumor grows rapidly and symptom will vary depending on the exact location and size of ... Read More
-
Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Kaposi Sarcoma (Infectious Disease) pipeline landscape. Kaposi's sarcoma is a cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and ... Read More
-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Leukemia (CML, Chronic Myeloid Leukemia) - Drugs In Development, 2022, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, ... Read More
-
Asia-Pacific Cancer Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... routine care in many healthcare facilities and had an impact on healthcare systems all around the world, putting susceptible cancer patients in serious danger. The strict lockdowns and government regulations intended to slow down the ... Read More
-
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape. Chronic lymphocytic leukemia (CLL) is a type of cancer that starts from white blood cells (called lymphocytes) in the ... Read More
Research Assistance
